Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2021-04-15 Capital/Financing Update
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
Capital/Financing Update Classification · 95% confidence The document is a Post-Effective Amendment No. 1 to a Registration Statement on Form S-1 filed with the SEC. It is related to the registration of securities for resale by selling stockholders. The document references the Securities Act of 1933 and includes detailed information about the offering, selling stockholders, and related legal and financial disclosures. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a transcript, audit report, or management discussion. The Form S-1 and its amendments are filings related to capital raising and securities registration. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length and content confirm it is a substantive filing, not a brief announcement or certification, supporting high confidence in classification.
2021-04-15 English
Regulatory Filings 2021
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. There is no indication of the document being a report itself or an announcement of a report. Due to the lack of identifiable information and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS). The document length is sufficient to exclude it being a mere announcement or certification, but the content is not interpretable for more specific classification.
2021-04-13 English
REGISTRATION STATEMENT
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes detailed information about the securities being offered, underwriting, risk factors, use of proceeds, and other disclosures typical of a registration statement for an initial or secondary public offering. This is not an annual report, earnings release, or any other type of financial report but a capital raising filing. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual registration statement, not just an announcement or summary.
2021-04-07 English
ANNUAL REPORT
Annual Report FY 2020
2021-03-16 English
CURRENT REPORT
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated February 8, 2021. It reports the submission of matters to a vote of security holders at the company's 2020 annual meeting. The content includes detailed voting results on three proposals: re-election of directors, ratification of the independent auditor, and approval of a corporate name change. The document explicitly states it is disclosing voting results from the Annual Meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 5296 characters, which is sufficient to contain substantive voting results rather than just an announcement of a report. Therefore, the correct classification is DVA with high confidence.
2021-02-11 English
CURRENT REPORT
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 8, 2021. It primarily discloses the mailing of a notice to shareholders regarding the upcoming annual shareholder meeting, including details about the virtual meeting and proxy materials. It states that voting results will be disclosed in an amendment after the meeting. The document does not contain financial statements or detailed financial data, nor is it a full annual report or earnings release. It is an announcement related to shareholder meeting materials and proxy solicitation. Given the content, it best fits the category of Proxy Solicitation & Information Statement (PSI), as it includes the notice and proxy card for the shareholder meeting. The document length is under 5,000 characters and it includes the notice as an exhibit, indicating it is the solicitation material itself, not just an announcement of a report. Therefore, the classification is PSI with high confidence.
2021-01-08 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.